Makers of copycat versions of Novo Nordisk's (NVO) weight-loss drug semaglutide, also known as Ozempic and Wegovy, are suing ...
Drug compounders on Monday sued the U.S. Food and Drug Administration over its decision last week to remove Novo Nordisk's ...
Glucagon-like peptite-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With ...
WEIGHT-loss drugs can be bought on the black market with no checks or consultation, The Sun has found. We obtained ...
For decades, scientists believed that infections were determined solely by viruses and bacteria. But Professor Jean-Laurent ...
The NoVo Foundation reported to the IRS that it had $545,384,793 in total assets value at the end of 2023. The organization reported $199,397,422 in contributions, gifts and grants paid. It ...
The Justice Department has launched an investigation into the company's Medicare billing practices, [The Wall Street Journal reported]( ...
The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, a declaration that will curtail ...
The FDA announcement confirms that the U.S. supply of both prescription-only drugs now meets or exceeds the current and ...
Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...
European stocks rose for a ninth straight week, boosted by shares of chemicals companies and Novo Nordisk A/S gains. Traders are also looking ahead to German elections on Sunday.
President Trump told reporters that tariffs on pharmaceuticals would start at "25% or higher," but did not say when they ...